Shmuel Levit M.D.

Head Of The Endocrinology And Diabetology Institute at Assuta Medical Centers Ltd.

Shmuel Levit, MD, PhD has extensive work experience in the medical field. Shmuel currently serves as the Founder and Board Member of LeviCure Ltd. In 2017, they became a Professor of Medicine at Kazan National Research Technological University. Prior to that, they held leadership positions at Assuta Medical Centers, including Head of the Endocrinology and Diabetology Institute and Head of the Endocrine Institute. Shmuel also served as the Head of the North-Israel Diabetes Service at Meuhedet and Head of the Diabetes Outpatient Clinic at Maccabi Health Services. Earlier in their career, they worked as a Senior Doctor at Sheba - Tel Ha SHomer Hospital, and held various roles at Assia Medical, Hillel Yaffe Medical Center, and Edith Wolfson Medical Center. Overall, Dr. Levit brings a wealth of expertise and leadership to their current role.

Shmuel Levit, MD, PhD, has an extensive education history spanning several years in the medical field. Shmuel began their education at the University of Chelyabinsk, where they completed their Medical degree (MD) from 1978 to 1984. During this time, they specialized in internal medicine through a Fellowship program at Chelyabinsk Regional Hospital #1 from 1984 to 1986.

In addition to their medical education, Dr. Levit pursued further studies in the field of endocrinology at Chelyabinsk Regional Institute of Endocrinology from 1985 to 1986.

Their passion for research led him to obtain a Doctor of Philosophy (PhD) degree from St. Petersburg Medical Academy of Postgraduate Studies between 1985 and 1990. Their PhD thesis, titled "Treatment of Autoimmune Thyroiditis with Levamisole and Epsilon – Aminocapronic Acid," focused on exploring innovative approaches to treating autoimmune thyroiditis.

Furthermore, Dr. Levit has demonstrated their commitment to innovation and advancement in the medical field by obtaining a patent for their work on the regenerative therapy of type 1 diabetes mellitus patients. This patent, titled "Combination treatment for the regenerative therapy of type 1 diabetes mellitus patients," was obtained in February 2018.

Overall, Shmuel Levit, MD, PhD, has a well-rounded education history, encompassing medical, research, and specialized studies.

Links

Timeline

  • A

    Head Of The Endocrinology And Diabetology Institute

    2012 - present